Clinical Study on Rimonabant - Acomplia®

Disclaimer: The medication here are registered trademarks of Sanofi-Aventis. We are not associated or affiliated with them in any way. Any information found here is provided for general informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use any of the information found here to diagnose or treat a health issue or disease or to prescribe any medication. Always seek medical advice from a medical doctor. Please read entire disclaimer.

In a clinical study, a group of patients where treated for 12 months with 20mg of rimonabant (Acomplia or Zimulti). And lost an average 20lbs verses the placebo group that lost 5 lbs. About 75% lost over 5% of their body weight and about 44% lost more than 10% of their body weight. The study also took into consideration some cardiovascular risks and found significant benefits including a 23% increase in "Good Cholesterol" levels (HDL-cholesterol - a high level seems to protect against heart attack.) There was an average reduction of 15% in triglycerides (the chemical form in which most fat exists in the body and are associated with cholesterol)